Search results for "NAD"

showing 10 items of 2033 documents

Tumor Volume, CT Scan, Lymphography, Sonography, Intravenous Pyelography, and Tumor Markers in Testis Tumors

1989

Correlation of tumor volume to tumor stage in 134 patients with nonseminomatous testicular tumors, which were classified according to the TNM system, revealed similar tumor load for N0 and N1 patients. CT scans (n = 92), lymphangiography (n = 47), intravenous pyelography (IVP) (n = 134), sonography (n = 118) and serial tumor markers (n = 82) were evaluated for sensitivity, specificity and accuracy, both separately and in different combinations. The best individual results were obtained by lymphangiography (sensitivity 0.77, specificity 0.73, accuracy 0.75) and CT scan (sensitivity 0.52, specificity 0.91, accuracy 0.70). In combination CT scan and lymphangiography were the most valuable diag…

AdultMalemedicine.medical_specialtyUrologyTesticular tumorComputed tomographyChorionic GonadotropinTesticular NeoplasmsTestis tumorsTestisTumor stageIntravenous PyelogramBiomarkers TumorHumansMedicineChorionic Gonadotropin beta Subunit HumanTumor LoadNeoplasm StagingUltrasonographymedicine.diagnostic_testbusiness.industryLymphographyUrographyIntravenous pyelographyNeoplasms Germ Cell and EmbryonalPeptide Fragmentsalpha-FetoproteinsRadiologyTomography X-Ray ComputedbusinessUrologia Internationalis
researchProduct

ACUTE VISION LOSS AS THE ONLY SIGN OF LEUKEMIA RELAPSE.

2016

Purpose To report a case of unilateral exudative retinal detachment as the sole presentation of relapsing B-type lymphoblastic leukemia in a 35-year-old man after 3 years of remission. Methods Case report. Results A 35-year-old man in complete remission of high-risk type B acute lymphoblastic leukemia (ALL-B) presented with acute vision loss in his left eye. Exudative retinal detachment was diagnosed at initial evaluation. Hematological and ocular studies were performed. Although there was no evidence of blood, cerebrospinal fluid, or bone marrow disease relapse, transvitreal retinochoroidal cytology identified the infiltration of lymphoblastic leukemic B cells with t(12:21) translocation a…

AdultMalemedicine.medical_specialtyVisual acuitymedicine.medical_treatmentBiopsyVisual AcuityVitrectomyAntineoplastic AgentsEndotamponadeBlindnessGastroenterology03 medical and health sciences0302 clinical medicineCerebrospinal fluidRecurrencehemic and lymphatic diseasesInternal medicineCytologyPrecursor B-Cell Lymphoblastic Leukemia-LymphomaVitrectomyBiopsymedicineHumansSilicone OilsB Acute Lymphoblastic Leukemiamedicine.diagnostic_testbusiness.industryRetinal DetachmentMagnetic resonance imagingGeneral MedicineExudative retinal detachmentFlow CytometryMagnetic Resonance ImagingOphthalmology030220 oncology & carcinogenesisAcute Disease030221 ophthalmology & optometrymedicine.symptomInjections IntraocularbusinessRetinal casesbrief reports
researchProduct

Diurnal coupling between testosterone and cortisol from adolescence to older adulthood

2016

The hypothalamic-pituitary-adrenal (HPA) and hypothalamic-pituitary-gonadal (HPG) axes are typically conceptualized as mutually inhibitory systems; however, previous studies have found evidence for positive within-person associations (i.e., coupling) between cortisol and testosterone. One developmental hypothesis is that positive testosterone-cortisol coupling is unique to the adolescent period and that coupling becomes attenuated, or even switches direction, in adulthood. This study used a lifespan sample (N = 292, ages 11 to 88) to test for age-related differences in coupling between cortisol and testosterone in daily life. Participants provided salivary hormone samples at waking, 30 minu…

AdultMalemedicine.medical_specialtyendocrine systemHypothalamo-Hypophyseal SystemEveningAdolescentHydrocortisoneEndocrinology Diabetes and MetabolismPituitary-Adrenal SystemDiurnal changeBiology050105 experimental psychologyArticle03 medical and health sciencesYoung Adult0302 clinical medicineEndocrinologyInternal medicinemedicineHumans0501 psychology and cognitive sciencesTestosteroneLongitudinal StudiesYoung adultChildGonadsSalivaBiological PsychiatryHydrocortisoneAgedAged 80 and overEndocrine and Autonomic Systems05 social sciencesTestosterone (patch)Middle AgedCoupling (electronics)Psychiatry and Mental healthEndocrinologyFemaleDual axis030217 neurology & neurosurgerymedicine.drugHormone
researchProduct

Patient-Reported Nonadherence with Glaucoma Therapy

2019

Abstract Purpose: Effective glaucoma therapy relies to a great extent on the patients' ability to regularly self-administer eye drops. This study aimed to assess self-reported nonadherence and to identify potential barriers to adherence in glaucoma patients. Methods: Participants completed a 16-item questionnaire, designed to examine nonadherence rate and assess the therapy experience. Inclusion criteria stipulated treatment duration of at least 1 year. Nonadherence was defined as missing ≥5% of the prescribed pressure-lowering eye drops doses. Results: In total, 201 glaucoma patients aged 24–88 years were included. Mean treatment duration was 9.4 years. Nonadherence was reported by 30.3% o…

AdultMalemedicine.medical_specialtygenetic structuresGlaucomaoutcomesYoung AdultGermanySurveys and QuestionnairesmedicineHumansPharmacology (medical)adherencePatient Reported Outcome MeasuresIntensive care medicineAntihypertensive AgentsAgedPharmacologyAged 80 and overnonadherencebusiness.industryPreservatives PharmaceuticalGlaucomaOriginal ArticlesMiddle Agedmedicine.diseaseeye diseasesOphthalmologyside effectsPatient ComplianceFemalesense organspreservativesInjections IntraocularOphthalmic SolutionsbusinessJournal of Ocular Pharmacology and Therapeutics
researchProduct

Safety and efficacy of alirocumab in a real-life setting: the ODYSSEY APPRISE study

2020

Abstract Aims To obtain safety and efficacy data of alirocumab, a proprotein convertase subtilisin/kexin type 9 inhibitor, in a real-life setting in high cardiovascular (CV) risk patients with heterozygous familial hypercholesterolaemia (HeFH) or very-high low-density lipoprotein cholesterol (LDL-C) levels despite maximally tolerated dose of statin ± other lipid-lowering therapies (MTD ± LLTs). ODYSSEY APPRISE was a prospective, single-arm, Phase 3b open-label (≥12 weeks to ≤ 30 months) European/Canadian study with alirocumab. Methods and results Patients received alirocumab 75 or 150 mg every 2 weeks, with dose adjustment based on physician’s judgment. In total, 994 patients were enrolled …

AdultMalemyalgiaCanadamedicine.medical_specialtyStatinEpidemiologymedicine.drug_class030204 cardiovascular system & hematologyAntibodies Monoclonal HumanizedReal life setting03 medical and health sciences0302 clinical medicineDose adjustmentInternal medicinemedicineHumansIn patientProspective Studies030212 general & internal medicineAdverse effectAgedAlirocumabbusiness.industryIncidence (epidemiology)Middle AgedTreatment OutcomeFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessEuropean Journal of Preventive Cardiology
researchProduct

A case of late diagnosis and management of 46 XY complete gonadal dysgenesis in adulthood

2021

AdultOvarian NeoplasmsPediatricsmedicine.medical_specialtyDelayed Diagnosisbusiness.industryObstetrics and GynecologyGonadal dysgenesisGonadal Dysgenesismedicine.diseaseLate diagnosismedicineHumans46 XY complete gonadal dysgenesis; prophylactic gonadectomy; germ cell tumor; difference of sex developmentbusinessGinekologia Polska
researchProduct

Concentrations of inhibins and activin in women undergoing stimulation with recombinant follicle-stimulating hormone for in vitro fertilization treat…

2001

To investigate the influence of human recombinant follicle-stimulating hormone (FSH) on circulating serum concentrations of the ovarian proteohormones inhibin A, inhibin B, pro alpha-C, and activin A and serum levels of estradiol after down-regulation with GnRH analogue.Serum concentrations of ovarian proteohormones and estradiol.Academic clinical practice.30 women who underwent assisted reproductive techniques.Blood samples were analyzed for inhibin A, inhibin B, pro alpha-C, activin A, and estradiol during IVF treatment at points coinciding with pituitary down-regulation, stimulation with recombinant FSH, ovulatory triggering, and the luteal phase of the cycle.Activin A levels did not cha…

AdultOvulationendocrine systemmedicine.medical_specialtyendocrine system diseasesmedicine.drug_classmedicine.medical_treatmentDown-RegulationFertilization in VitroLuteal PhaseLuteal phaseBiologyFollicle-stimulating hormoneFollicleOvarian FolliclePregnancyInternal medicineFollicular phasemedicineHumansInhibinsreproductive and urinary physiologyUltrasonographyIn vitro fertilisationEstradiolObstetrics and GynecologyRecombinant Proteinsfemale genital diseases and pregnancy complicationsActivinsEndocrinologyReproductive MedicineEstrogenFemaleFollicle Stimulating HormoneGonadotropinhormones hormone substitutes and hormone antagonistsHormoneFertility and Sterility
researchProduct

High progesterone levels in women with high ovarian response do not affect clinical outcomes: a retrospective cohort study

2014

Background The potentially detrimental role of progesterone during the follicular phase has been a matter of controversy for several years; however, few studies have analyzed the effects of combined raised estradiol and progesterone levels on pregnancy outcomes. The aim of the present study was to determine the influence of high progesterone levels on clinical outcomes in the context of high ovarian response. Methods We performed a retrospective cohort study that included 2850 women classified as high responders. The women were subdivided into six groups depending on their progesterone concentration on the day of human chorionic gonadotropin (hCG) administration: 1.81 ng/ml (>p90). Ovarian …

AdultPregnancy Ratemedicine.medical_treatmentContext (language use)Fertilization in VitroBiologyChorionic GonadotropinHuman chorionic gonadotropinCohort StudiesAndrologyYoung AdultOogenesisEndocrinologyOvulation InductionPregnancyHigh progesteroneClinical outcomesFollicular phasemedicineHumansChorionic Gonadotropin beta Subunit HumanSperm Injections IntracytoplasmicProgesteroneRetrospective StudiesPregnancyEstradiolResearchOvaryObstetrics and GynecologyRetrospective cohort studyFertility Agents Femalemedicine.diseaseUp-RegulationPregnancy rateFollicular PhaseROC CurveReproductive MedicineSpainHigh respondersFemaleOvulation inductionOvarian responseInfertility FemaleCohort studyDevelopmental BiologyReproductive Biology and Endocrinology
researchProduct

Ovarian suppression reduces clinical and endocrine expression of late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

1994

Objective To determine the effectiveness of GnRH-agonist (GnRH-a) treatment in women with late onset congenital adrenal hyperplasia. Design Prospective assessment of GnRH-a treatment in six women with documented late-on-set congenital adrenal hyperplasia who were not preselected. Comparisons were made to previous responses in the same patients receiving dexamethasone. Eight age- and weight-matched ovulatory women served as controls. Setting Academic medical center. Intervention Baseline blood determinations before and after IV ACTH, before and after 6months of GnRH-a treatment. Estrogen and progestin replacement was begun in all women after the 3rd month of treatment. Main Outcome Measures …

Adultendocrine systemmedicine.medical_specialtyHirsutismAdolescentmedicine.drug_classOvaryDexamethasoneInternal medicineEndocrine GlandsmedicineHydroxyprogesteronesHumansCongenital adrenal hyperplasiaProspective StudiesAge of OnsethirsutismDexamethasoneTriptorelin PamoatebiologyAdrenal Hyperplasia Congenitalbusiness.industry17-alpha-HydroxyprogesteroneOvary21-HydroxylaseObstetrics and Gynecologymedicine.diseaseAndrogenmedicine.anatomical_structureEndocrinologyReproductive MedicineEstrogenbiology.proteinAndrogensFemalebusinessProgestinhormones hormone substitutes and hormone antagonistsGonadotropinsmedicine.drugFertility and sterility
researchProduct

Inverse correlation between baseline inhibin B and FSH after stimulation with GnRH: a study of serum levels of inhibin A and B, pro alpha-C and activ…

2000

OBJECTIVE: Interest has focused recently on the influences of the polypeptide factors inhibin and activin on the selective regulation of the pituitary secretion of gonadotropins. DESIGN: Measurement of the concentrations of inhibin-related proteins in relation to the changes in pituitary gonadotropin (FSH, LH) parameters, after GnRH stimulation with a bolus injection of 100 microg gonadorelin, in 19 women with ovulatory disturbances. METHODS: Serum levels of inhibin A and B, activin A, and pro alpha-C were measured using sensitive ELISA kits. RESULTS: Within 60 min after GnRH stimulation, FSH values doubled from 5 to 10 mU/ml (P < 0.001). LH increased 12-fold from 2 to 24 mU/ml (P < 0…

Adultendocrine systemmedicine.medical_specialtyInhibin aAdolescentmedicine.drug_classEndocrinology Diabetes and MetabolismAlpha (ethology)StimulationGonadotropin-releasing hormoneGonadotropin-Releasing HormoneFollicle-stimulating hormoneEndocrinologyInternal medicinemedicineHumansInhibinsOvarian DiseasesAmenorrheaEstradiolChemistryHypogonadismGeneral MedicineLuteinizing HormoneActivinsEndocrinologyAmenorrheaFemaleGonadotropinmedicine.symptomFollicle Stimulating HormoneLuteinizing hormonehormones hormone substitutes and hormone antagonistsHypothalamic DiseasesEuropean journal of endocrinology
researchProduct